Palisade Bio, Inc.

US$1.13As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PALIHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (78.63%)
Div yield —
ROE (51.37%)
Biotechnology
Beta (5Y) 1.62
PE TTM —
TSR TTM (45.41%)
Mkt cap US$196.9M
ROIC (35.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.43
26.98%
87.59%
Hold 7|5|11|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
9.36%
9.19%
24.66%
22.95%
Revenue$M
21.02
21.27
20.81
21.98
(0.84%)
(2.19%)
(2.49%)
5.97%
Peers (US$196.9M)
Cap (US$)
PE
202.5M
—
Capital
TTM
5Y
10Y
Leveragex
4.096
0.152
0.141
EBIT/Intx
1.910
0.096
0.098
Own earn%
(30.41)
235.74
201.85
Sh yield%
42.76
31.05
33.28
Owners
Insiders/Inst%
1.48
57.73
Short interest%
4.57
SBC / revenue%
0.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
29–34
$1 testx
0.0
Incr. ROIC%
12